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Abstract 30 
The development of abdominal aortic aneurysm (AAA) associated thrombi play an important role 31 
during the onset and progression of AAAs. The aim of this study was to evaluate the potential of 32 
high-frequency-ultrasound for characterization of AAA associated thrombi in an apolipoprotein-33 
E-deficient (ApoE-/-) mouse-model. Ultrasound measurements were performed using a high-34 
resolution ultrasound-system (Vevo770, VisualSonics, Canada) with a 30MHz linear-array-35 
transducer (RMV707B). Magnetic resonance imaging with a 3 Tesla scanner (Achieva MR 36 
system, PhilipsHealthcare, Best, Netherlands) and a single-loop microscopy-coil was performed 37 
as a reference standard.  38 
All stages of aneurysm development were evaluated by histological analyses. The “signal-39 
thrombus-matrix” to “signal-blood” ratio on high-frequency ultrasound-measurements showed a 40 
strong correlation (R²=0.81,p<0.05) with the state of extracellular-matrix-remodeling. 41 
Furthermore, size measurements derived from the high-frequency-ultrasound correlated well with 42 
MRI and histology.  43 
This study demonstrated, that high-frequency-ultrasound enables the reliable in vivo quantification 44 
of extracellular matrix remodeling at different stages of thrombus development based on the 45 
thrombus echogenicity. 46 
 47 
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Introduction   55 
Cardiovascular diseases are consistently ranked among the leading causes of death in developed 56 
and developing countries (Krishnan, et al. 2010). Among cardiovascular diseases, abdominal aortic 57 
aneurysms (AAAs) represent the third leading cause of death. As a result of the increased aging of 58 
the population, their incidence is constantly rising (Hallett 2000). If undiagnosed or untreated, 59 
AAAs can increase in size over time, which is associated with a higher risk of rupture (Thompson, 60 
et al. 2002).  61 
It is widely assumed that the rupture of the elastic laminae in the tunica media leads to a dissection 62 
of the aortic wall, which subsequently results in the development of an aortic aneurysm. 63 
Simultaneously, the blood clotting cascade is activated, causing the formation of a small focal 64 
fibrin-rich hematoma at the rupture site (Saraff, et al. 2003). If the aneurysm continues to increase 65 
in size, a large fibrin-rich thrombus develops. During the early stage of AAA development, the 66 
thrombus is primarily composed of fibrin, which is associated with the coagulation of blood in the 67 
aneurysmatic vessel wall. During the further development of the aneurysm, the fibrin rich 68 
thrombus is increasingly stabilized due to extracellular matrix expression by macrophages and 69 
smooth muscle cells. This leads to the development of an extracellular matrix rich in elastin and 70 
collagen, while the hemorrhage associated fibrin is subsequently replaced   71 
During further progression of the aortic aneurysm, there are different multifactorial pathways, 72 
resulting either in a further extracellular matrix synthesis and stabilization of the thrombus matrix 73 
or to a degradation of the extracellular matrix with a potential destabilization of the thrombus. This 74 
process is thought to be highly relevant for the outcome of AAAs (Huffman, et al. 2000, Krettek, 75 
et al. 2003, Saraff, et al. 2003). Therefore, the detection and characterization of AAA associated 76 
thrombi might represent an important factor for the further evaluation of aneurysms. 77 
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Even though human AAAs represent a relatively frequent vascular disease, their pathogenesis is 78 
not fully understood yet. This is because of the difficulty to obtain in vivo tissue samples from 79 
aortic aneurysms. Therefore, pre-clinical animal models of AAAs are important to increase our 80 
understanding of the different factors which cause the development and destabilization of aortic 81 
aneurysms. For the generation of AAAs several different small animal models of AAA have been 82 
described (Trollope, et al. 2011). The administration of Angiotensin II (AngII) via subcutaneous 83 
implanted osmotic minipumps in apolipoprotein E-deficient (ApoE-/-) mice represents the most 84 
frequently used technique, as AAAs develop spontaneously without requiring surgical intervention 85 
at the aorta (Daugherty, et al. 2000). Previous studies investigating aortic aneurysms in this ApoE-86 
/- mouse model (Cao, et al. 2010, Nandlall, et al. 2014) have so far not investigated specific 87 
differences in echogenicity and composition of AAA associated thrombi using in vivo high-88 
frequency ultrasound.  89 
The aim of this study was to evaluate the potential of high-frequency-ultrasound for in vivo 90 
characterization of AAA associated thrombi in an apolipoprotein E-deficient (ApoE-/-) mouse-91 
model. Histopathology was used as ex vivo reference standard. Magnetic resonance imaging 92 
(MRI) was used to validate the in vivo findings regarding the detection of AAA associated thrombi. 93 
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Materials and Methods 94 
Animal experiments  95 
All procedures were performed according the guidelines and regulations of the United Kingdom 96 
Home Office. Aortic abdominal aneurysms were created in male, homozygous C57BL/6J ApoE 97 
knockout mice (8 weeks old) from Charles River Laboratories (Edinburgh, UK) by osmotic mini 98 
pump implantation. After intramuscular administration of a combination of Medetomidin (500 99 
µg/kg), Fentanyl (50 µg/kg) and Midazolam (5 mg/kg), a minipump (Alzet model 2004, Durect 100 
Corp, Cupertino, CA, United States), was implanted subcutaneously in the dorsal region of the 101 
neck. Angiotensin II or saline (sham-operated group, n=6) were continuously infused with a rate 102 
of 1µg/kg/min over a course of 4 weeks. After one, two, three and four weeks of Angiotensin II 103 
infusion an ultrasound and MRI imaging session was performed in general anesthesia. At each 104 
time point, eight animals were scanned. Following the imaging, mice were euthanized and 105 
exsanguinated by arterial perfusion of phosphate buffered saline at a pressure of 100 mm Hg. For 106 
histological examinations, an additional perfusion of 10% formalin was performed followed by 107 
excision of the aorta including the right renal artery and last pair of intercostal arteries.  108 
 109 
In vivo ultrasound imaging 110 
To perform high-frequency ultrasound imaging, animals were anesthetized and placed supine on 111 
a heated table. Hair was removed using a depilatory cream. 2D-transverse and sagittal images of 112 
the suprarenal abdominal aorta were performed using a Vevo 770 high-resolution ultrasound 113 
imaging system (VisualSonics, Toronto, Canada) with 30 MHz transducer (RMV 707B). Cine 114 
transversal and sagittal images were acquired by the ECG-based kilohertz visualization (EKV) 115 
reconstruction technique that synthesizes images from a series of heart rhythm cycles and 116 
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reconstructs one representative heart cycle that is spatially precise and synchronized to the 117 
animal’s ECG (VisualSonics software, Toronto, Canada).  118 
For in vivo ultrasound imaging a field of view (FOV) of 12.0 x 12.0 mm2 was used. The axial 119 
spatial resolution was 55 µm. A lateral spatial resolution of 115 µm was achieved. For the ECG-120 
based kilohertz visualization (EKV) modus provided by the ultrasound system the signal element 121 
transducer worked on a line by line principal. The transducer received and transmitted a pulse 122 
repetition frequency of 8000 Hz. A signal on the radiofrequency signal indicated the time of pulse 123 
transmission for all imaging data acquisition. The electrocardiogram (ECG) was in all animals 124 
derived using electrodes available on the fixation module.   125 
 126 
Animal handling and in vivo magnetic resonance imaging 127 
All imaging sessions were performed using a clinical 3 Tesla Achieva MR system (Philips 128 
Healthcare, Best, The Netherlands) with a clinical gradient system (30mT/m, 200mT/m/ms) and a 129 
microscopy coil (47 mm, Philips healthcare, Best, the Netherlands). Following anesthesia 130 
injection, the animals were positioned in a supine position on the microscopy (47 mm in diameter) 131 
single loop coil. During the imaging session body temperature (37°C) was monitored using a MR-132 
compatible heating system (Model 1025, SA Instruments Inc, Stony Brook, NY, United States). 133 
To localize the abdominal aorta, a low-resolution three-dimensional gradient echo scout scan was 134 
performed with the following imaging parameters: Imaging matrix = 160 x 160, field of view = 20 135 
x 20x 10 mm, slice thickness = 0.5 mm, inplane spatial resolution=0.3 x 0.3 mm (reconstructed 136 
0.13 x 0.13 mm), flip angle = 60 °, repetition time (TR) sequence = 37 ms and echo time (TE) 7.7 137 
ms. Subsequently, for specific visualization of the aorta a 2D TOF angiography (two-dimensional 138 
time-of-flight angiography) in transverse orientation was performed using the same parameters. 139 
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Imaging parameters of the inversion recovery 3D fast gradient echo MRI scan were field of view 140 
= 3 cm, imaging matrix =300, spatial resolution inplane = 0.1×0.1, slice thickness 0.5 mm 141 
(reconstructed slice thickness=0.25 mm), 40 slices, repetition time /echo time= 28 / 8.2 ms, flip 142 
angle = 30 degrees. 143 
 144 
Aortic aneurysm morphometry 145 
Following exsanguination, the suprarenal aorta, including the last pair of intercostal artery 146 
branches and the right renal artery were surgically excised. The left renal artery and the last pair 147 
of intercostal artery branches were used as landmarks for a coregistration of histology with high-148 
frequency ultrasound and MR imaging. Morphometric measurements were performed on elastin–149 
stained sections using ImageProPlus software (ImageProPlus, MediaCybernetics, Rockville, MD, 150 
United States). The percentage Miller’s Elastica van Gieson (EvG) stain per adventitial area in the 151 
region enclosed by the adventitia and the lumen was assessed. The percentage calculation was 152 
performed manually. First the overall area of the Elastica van Giesson stain was assessed and in a 153 
second step the overall adventitial area was measured. Then, the percentage calculation was 154 
performed based on these values. These techniques have been previously described in (Botnar, et 155 
al.) for the characterization of matrix remodeling. 156 
 157 
Echogenicity of AAA associated thrombi 158 
For the assessment of the echogenicity of AAA associated thrombi, a “signal thrombus matrix” to 159 
“signal blood” ratio was established. Region of interests (ROIs) were drawn to assess the signal of 160 
the thrombus as well as the blood. Signal measurements were performed in the transversal and 161 
sagittal image orientation at the location of the largest thrombus area. The mean between both 162 
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values was calculated. For both ultrasound and magnetic resonance imaging, the drawing of the 163 
region of interests (ROIs) was performed using the OsiriX software (version 5.8). All regions of 164 
interest in ultrasound and magnetic resonance imaging were manually identified and drawn. In all 165 
animals, aortic aneurysms could be clearly distinguished from the surrounding tissues. In 166 
ultrasound, the thrombus was detected based on the relative dark signal of the thrombus compared 167 
to the relatively bright signal of surrounding tissues. On MRI, the thrombus could be identified 168 
based on the typical T1 signal changes of thrombus tissue, compared to the surrounding tissue. 169 
 170 
Histological and immunohistochemical analysis of aortic aneurysms 171 
Aortas were perfused with 10% formalin followed by excision of the abdominal aortic aneurysm. 172 
For histological sections, aneurysms were embedded in paraffin and cut every 40 µm, starting from 173 
the proximal end of the aneurysm. The sections (6 µm) were subsequently stained for Miller’s 174 
Elastica van Gieson stain and hematoxylin and eosin (HE). For morphology measurements the 175 
percentage calculation was performed manually. First the overall area of the Elastica van Giesson 176 
stain was assessed and in a second step the overall adventitial area was measured. Then, the 177 
percentage calculation was performed based on these values. 178 
 179 
Interobserver agreements for high-frequency ultrasound measurements 180 
All images were analyzed independently in a randomized order and blinded to the according other 181 
imaging modalities. Area size was recorded for each measurement. 182 
 183 
Statistical analysis 184 
Data are expressed as mean ± standard deviation. To determine continuous variables, a student’s 185 
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t-test (unpaired, 2-tailed) was used. Statistical comparison of groups was performed by analysis of 186 
variance (ANOVA) followed by the Bonferroni correction. P<0.05 was used to indicate 187 
significance.  188 
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Results 189 
Development of abdominal aortic aneurysms and associated thrombi 190 
In the control or sham animals, no development of AAAs was observed (Fig. 1). In the disease 191 
group, the continuous infusion of Angiotensin II in ApoE-/- mice led to a reliable development of 192 
AAAs in vivo (Fig. 2). Using high-frequency ultrasound, the normal healthy aorta and the aortic 193 
dilation at different stages of AAA development could be clearly visualized (Fig. 2). In the control 194 
group the abdominal aortic area was the smallest (1.09 ± 0.16 mm²) and no thrombus was detected. 195 
In the Angiotensin II group, a steady increase of the size of the aortic lumen was observed from 196 
week one to week four (2.26 ± 0.92 mm² to 3.87 ± 1.26 mm²). After one week, an average thrombus 197 
area of 2.23 ± 0.71 mm² was measured using high-frequency ultrasound. After two weeks of 198 
Angiotensin II infusion an average area of 2.48 ± 0.81 mm² was measured. The increase in 199 
thrombus area plateaued after three and four weeks within average area of 2.89 ± 0.77 mm² and 200 
2.86 ± 0.90 mm². 201 
 202 
Quantification of thrombus remodeling by high-frequency ultrasound compared to 203 
histopathology 204 
Using high-frequency ultrasound, it was not only feasible to detect the development of AAA 205 
associated thrombi, but it was also possible to assess relative signal differences in echogenicity of 206 
the thrombus matrix at different stages of aneurysm development. Fresh thrombi early after the 207 
onset of AAA development (one week) showed a relatively low echogenicity (dark thrombus 208 
matrix) with a “signal thrombus matrix” to “signal blood” ratio of 1.61 ± 0.33 (Fig. 2 a2). After 209 
two weeks a slight, however, not significant increase of signal to 1.82 ± 0.29 was observed. After 210 
three weeks a significant (p < 0.05) increase in signal (inhomogeneous bright thrombus matrix, 211 
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Fig. 2 a7) with a “signal thrombus matrix“ to “signal blood” ratio to 2.05 ± 0.44 was measured, 212 
reflecting a remodeling of the extracellular matrix on histopathology (Fig. 2 a10). After four weeks 213 
a further, however, smaller increase of “signal thrombus matrix“ to “signal blood” ratio of 2.14 ± 214 
0.52 was observed, indicating a further remodeling.  215 
On histopathology, the development of an AAA associated thrombus was observed one week after 216 
onset of the Angiotensin II infusion. The matrix of the thrombi at such an early stage did not show 217 
relevant signs of remodeling (Fig. 2 a4, a5). Only a relatively low percentage (7.8 ± 3.5 %) of 218 
elastic fibers was measured on the Elastica van Giesson stain, resulting mainly from the “normal” 219 
elastic lamina in the aortic wall. During week two, a slight increase (10.4 ± 1.7 %) in expression 220 
of elastic fibers was seen on histopathology. On week three, a relatively strong and pronounced 221 
remodeling of the thrombus (13.2 ± 3.7 %) with a strong expression of elastic fibers was observed 222 
in the Elastica van Giesson stain. The elastic fibers were expressed throughout the whole matrix 223 
of the thrombus. Additionally, a remodeling of the surrounding adventitia with elastic fibers was 224 
observed. At week four a slight however not significant additional increase (14.29 ± 4.13 %) in 225 
elastic fiber expression was measured (Fig. 2 a10). A significant difference in “signal thrombus 226 
matrix” to “signal blood” ratio was measured between week one and week three (p < 0.05) and 227 
between week two and week four (P < 0.05, Fig. 3a). Additionally, the correlation between the 228 
echogenicity of the thrombus (“signal thrombus matrix” to “signal blood” ratio) measured by high-229 
frequency ultrasound and the relative elastin expression (“elastin stain area” to “adventitial area 230 
ratio”) measured by ex vivo histology was assessed (Fig. 3b). A close and significant correlation 231 
between these in vivo and ex vivo measurements was found (y = 0.10x + 0.81, R² = 0.81, p<0.05). 232 
 233 
Detection of AAA associated thrombus and assessment of thrombus size using high-234 
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frequency ultrasound compared to magnetic resonance imaging and histopathology   235 
The AAA associated thrombus size was assessed in vivo using both, high-frequency ultrasound 236 
and magnetic resonance imaging in the same animals (Fig. 2). At all stages of disease development, 237 
in vivo high-frequency ultrasound enabled a clear visualization of the thrombus, compared to MRI 238 
as reference standard. In vivo thrombus size measurements using high-frequency ultrasound 239 
showed a close correlation with in vivo magnetic resonance imaging (y = 0.87x + 0.003, R² = 0.92, 240 
p < 0.05) (Fig. 4). No significant differences (p < 0.05) between absolute size measurements 241 
existed between high-frequency ultrasound and magnetic resonance imaging. 242 
In vivo high-frequency ultrasound measurements also showed a close correlation with ex vivo size 243 
measurements on histopathology using the Elastica van Giesson stain (y = 1.21x + 0.26, R² = 244 
0.87,). In vivo area measurements in high-frequency ultrasound were slightly larger compared to 245 
area measurements and ex vivo histology, however differences were not significant (p > 0.05). 246 
The trend towards smaller size measurements on ex vivo histology can be explained by tissue 247 
shrinkage, which results from the processing of the tissue samples. In vivo magnetic resonance 248 
imaging also showed a close correlation with ex vivo measurements of thrombus size (y = 1.20x - 249 
0.014, R² = 0.93).   250 
 251 
Interreader agreement for the assessment of thrombus size using high-frequency ultrasound 252 
The reproducibility of high-frequency ultrasound size measurements was also investigated by two 253 
readers. Interobserver correlation for thrombus area measurements in high-frequency ultrasound 254 
showed a strong and significant correlation between both readers (R2 = 0.86; p < 0.05) (Fig. 5). 255 
95% confidence intervals (CIs) ranged from -0.57 to 0.62. The reproducibility of magnetic 256 
resonance measurements was also assessed. A close interobserver correlation (R2 = 0.88; p < 0.05) 257 
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was measured. The associated 95% confidence intervals were small with a range from -0.40 to 258 
0.59. 259 
 260 
 261 
 262 
 263 
 264 
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Discussion 265 
This study demonstrated, that high-frequency-ultrasound enables the reliable in vivo quantification 266 
of extracellular matrix remodeling at different stages of thrombus development based on the 267 
thrombus echogenicity. Late stage highly remodeled thrombi showed a significantly higher 268 
echogenicity compared to early/fresh fibrin rich thrombi. As highly remodeled thrombi were 269 
shown to stabilize aortic aneurysms, such an in vivo parameter could be useful for the assessment 270 
of the AAA associated rupture risk (Saraff, et al. 2003). 271 
 272 
Clinical relevance of aortic aneurysms and imaging modalities for the detection of aortic 273 
aneurysms 274 
As a consequence of their constantly increasing incidence and their fatal complications in case of 275 
rupture, the role of AAAs in the population becomes more and more important (Schmitz-Rixen, et 276 
al. 2016). In most cases, AAAs are asymptomatic until rupture occurs. In approximately 75% of 277 
patients the rupture of AAA is lethal (Bown, et al. 2002). Currently, it is recommended that patients 278 
with aneurysms larger than 5.5 cm and/or with a growth rate of more than 1 cm a year should 279 
undergo surgery. In small aneurysms (< 3.5 cm) close follow-up investigations by imaging can be 280 
performed. However, there is an ongoing debate regarding the best possible management of 281 
medium sized (4 to 5.5 cm) AAAs (Lederle, et al. 2002). Consequently, novel biomarkers are 282 
needed to improve assessment of the AAA risk of rupture. Up to date, the only clinically 283 
established parameter is the aortic diameter, which is measured in vivo. Different studies 284 
demonstrated that this parameter is limited regarding the prognosis of AAA progression and 285 
rupture (Lederle, et al. 2002). Additionally, aortic diameter has so far not been validated as a 286 
reliable risk factor by population-based studies (Sharp and Collin 2003).  287 
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Due to the absence of symptoms during the development of aortic aneurysms, early diagnosis 288 
remains challenging. In clinical practice abdominal ultrasound, computed tomography (CT) and 289 
magnetic resonance imaging represent the current reference standard for the assessment of AAAs. 290 
Each of these imaging modalities was shown to have a high diagnostic sensitivity for the detection 291 
of aortic aneurysms in vivo (Thompson, et al. 2002) as well as a high spatial resolution and soft 292 
tissue contrast (Buijs, et al. 2013, Forsythe, et al. 2016, Hong, et al. 2010, Sakalihasan, et al. 2005). 293 
However, computed tomography and magnetic resonance imaging are relatively cost intensive 294 
imaging modalities and CT has the additional disadvantage of using ionizing radiation, which is 295 
especially relevant in a young patient collective and in patient collectives which require recent 296 
follow-up examinations. By contrast, ultrasound imaging is a reliable, cost effective and radiation 297 
free method for the assessment, follow-up surveillance as well as population screening of patients 298 
with suspected aortic aneurysms (Buijs, et al. 2013, Sakalihasan, et al. 2005).  299 
 300 
Experimental models for the characterization of AAAs 301 
Experimental models play an important role for the investigation of the pathophysiology of AAAs 302 
as they enable the simulation of these changes in vivo. Because of their excellent genetic and 303 
physiological characterization, the majority of experiments are performed with rodents 304 
(Brockmann, et al. 2007). Several different animal models have been developed for studying the 305 
pathology of aortic aneurysms (Trollope, et al. 2011). AngII infusion of apolipoprotein E-deficient 306 
mice via osmotic minipumps with the associated increase in blood-pressure represents one of the 307 
most frequently used models with a reliable and fast development of AAAs (Daugherty, et al. 308 
2000). Another advantage of this model is, that AAAs develop spontaneously and are highly 309 
reproducible, while no surgical intervention in the aorta is required.  310 
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Ultrasound for the detection and characterization of AAA associated thrombi   311 
The published literature investigating high-frequency ultrasound in the ApoE-/- mouse model with 312 
angiotensin II minipumps so far focused on the identification of aneurysms as well as size 313 
measurements or staging. Cao et al. (Cao, et al. 2010) studied the fluid mechanics in developing 314 
AAAs by ultrasound imaging and examined macrophage infiltration. Complex fluid flow patterns 315 
in AAAs were observed and already evident at day 7 post-Ang II infusion with unsteady flow, 316 
shed vortices that impinge upon the distal wall, and re-circulating flow which play a critical role 317 
in growth and rupture of AAAs. Furthermore, prominent inflammatory macrophage infiltration at 318 
the site of elastic media breakdown could be found. Although they identified an area in which local 319 
fluid mechanics are favorable to the formation of thrombus, there were no further investigation 320 
regarding thrombus composition or remodeling. Another group (Nandlall, et al. 2014) used Pulse 321 
Wave Imaging (PWI) to monitor and stage AAA progression. In AAA sacs, wave speeds were 322 
significantly lower and exhibit more variability. Additionally, fissured or ruptured AAAs showed 323 
changes in the wall displacements induced by pulse waves. An observed reduction in displacement 324 
in the aneurysm sacs could be explained by the presence of a thrombus but no further investigation 325 
of  the thrombus itself were made. This study hypothesized that PWI could be used in future to 326 
supply complementary information to that provided by standard B-mode imaging.  Martin-327 
McNulty et al. (Martin-McNulty, et al. 2005) and Barisione et al. (Barisione, et al. 2006) were the 328 
first to establish high-frequency ultrasound for detection of AAAs in mice. Both studies analyzed 329 
the lumen dimensions by two dimensional ultrasound imaging and histologic analysis of the same 330 
regions, which shows a close agreement.  In contrast to these studies, this study investigated 331 
specific differences in echogenicity and composition of AAA associated thrombi.   332 
The majority of AAAs is associated with a thrombus that adheres to the aneurysmal wall (Hans, 333 
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et al. 2005, Kazi, et al. 2005, Labruto, et al. 2011, Vorp, et al. 2001). Clinical studies have shown 334 
that transabdominal ultrasound enables the detection of AAA associated thrombi (Wanhainen, et 335 
al. 2002). However only a limited number of clinical studies have specifically investigated the 336 
composition of thrombi in vivo using ultrasound. In general, it was shown that thrombi are 337 
relatively echogenic compared to the echo free aortic lumen. Additionally, it was demonstrated 338 
that ultrasound enables the detection of fissures and dissections in AAA associated thrombi 339 
(Wanhainen, et al. 2002). To the best of our knowledge, specific differences in echogenicity of 340 
AAA associated thrombi has not been specifically evaluated yet. However, in the context of 341 
atherosclerosis, factors which lead to a change of echogenicity have been investigated. Based on 342 
histological analysis it was suggested that echolucent plaques are rich in hemorrhage/fibrin and 343 
lipid (Gronholdt, et al. 2001, Mathiesen, et al. 2001, Tegos, et al. 2001). In contrast, echogenic 344 
plaques were shown to be rich in fibrous tissue, which is mainly composed of extracellular matrix 345 
proteins, including elastin and collagen (Gronholdt, et al. 1997, Kardoulas, et al. 1996). These 346 
observations are in line with our current study, in which we evaluated the potential of high-347 
frequency ultrasound for the detection and characterization of AAA associated thrombi. Using 348 
high-frequency ultrasound, it was possible to evaluate the structure of the thrombus matrix and 349 
therefore to assess its state of remodeling. As described for atherosclerotic plaques, late stage AAA 350 
associated thrombi, which are rich in extracellular matrix proteins (e.g. elastin), show a higher 351 
echogenicity compared to early/fresh thrombi which are rich in fibrin/hemorrhage. A close 352 
correlation between echogenicity, measured by in vivo ultrasound, and extracellular matrix 353 
remodeling, measured in ex vivo histology, was found. In addition, a high interobserver 354 
reproducibility was found for ultrasound as well as MRI measurements. 355 
Since late stage highly remodeled thrombi were shown to stabilize aneurysms  (Adolph, et al. 356 
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1997, Li, et al. 2008, Saraff, et al. 2003, Thubrikar, et al. 2003, Wang, et al. 2002), this imaging 357 
approach may represent a new diagnostic tool to improve the risk stratification of patients and to 358 
guide therapeutic interventions.   359 
 360 
Limitations 361 
One limitation of the used experimental model might be that the location of AAA varies between 362 
humans and mice. While AAAs in mice develop in the suprarenal aorta, human AAAs develop in 363 
the infrarenal part of the aorta. It is assumed that differences in aortic wall composition and 364 
hemodynamics might contribute to this difference.  365 
 366 
Conclusion 367 
This study demonstrated, that high-frequency-ultrasound enables the reliable in vivo quantification 368 
of extracellular matrix remodeling at different stages of thrombus development based on the 369 
thrombus echogenicity. 370 
 371 
 372 
 373 
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Figure Captions List 476 
Figure 1: In vivo imaging of the abdominal aorta in sham operated apolipoprotein E-477 
deficient (ApoE -/-) mice  478 
After 4 weeks of continuous saline infusion via subcutaneously implanted osmotic minipumps 479 
(n=6), ultrasound (a1-2, a6) and magnetic resonance (MR) (a3, a7) imaging were performed. 480 
Longitudinal and corresponding transverse ultrasound images (a1-2, a6) as well as transverse MR 481 
images (a3, a7) show no dilatation or alterations of the aortic wall. The red and orange lines (a1) 482 
indicate the location of the corresponding transverse images. Histological sections (a4-5, a8-9) 483 
showed an intact vessel wall without dilatation. EvG indicates Elastica van Gieson staining; HE, 484 
hematoxylin and eosin staining. Ao: Aorta. 485 
 486 
 487 
Figure 2:  Development and remodeling of abdominal aortic aneurysm (AAA) associated 488 
thrombi in apolipoprotein E-deficient (ApoE-/-) mice 489 
Longitudinal and corresponding transverse ultrasound images of an ApoE-/- mouse after one week 490 
(a1,2) and four weeks (a6,7) of Angiotensin II (AngII) infusion (n=8 per group). The formation of 491 
an AAA associated intramural thrombus was observed. The perimeter of the thrombus is outlined 492 
by the orange and red dotted line (a2-3, 7-8). Transverse magnetic resonance images (a3, a8) of 493 
the same segment show similar characteristics. Histological sections confirmed rupture of the 494 
elastic laminae and fibrin rich thrombus formation (a4-5, including magnification). After four 495 
weeks of AngII infusion, a strong remodeling of the thrombus matrix was observed (a9-10). The 496 
magnification demonstrates a high expression of extracellular matrix proteins, including elastic 497 
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fibers. EvG indicates Elastica van Gieson staining; HE, hematoxylin and eosin staining. Ao: Aorta, 498 
Th: Thrombus. 499 
 500 
 501 
Figure 3: In vivo assessment of thrombus echogenicity in correlation to thrombus remodeling  502 
a: Weekly in vivo ultrasound imaging (n=8 per group) of the thrombus matrix over the time course 503 
of Angiotensin II (AngII) infusion resulted in the detection of a significant and constantly 504 
increasing echogenicity (signal thrombus to signal blood ratio) of the thrombus matrix. In sham 505 
operated mice no thrombus formation was observed. b: A significant correlation (R2 = 0.81) 506 
between the echogenicity of the thrombus measured by high-frequency ultrasound and the relative 507 
elastin expression (“elastin stain area” to “adventitial area ratio”) measured by ex vivo histology 508 
was observed. Values are expressed as mean±SD. 509 
 510 
 511 
Figure 4: Comparison of in vivo and ex vivo measurements of thrombus area in abdominal 512 
aortic aneurysm (AAA) 513 
To further validate in vivo high-frequency ultrasound measurements, thrombi areas were assessed 514 
at the same location by in vivo ultrasound and ex vivo histology. A significant correlations (p < 515 
0.05) between in vivo ultrasound (a) and ex vivo histology were observed (R2 = 0.87).  516 
 517 
 518 
Figure 5: Inter-observer variability for ultrasound measurements  519 
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a, b: Inter-observer variability for in vivo high-frequency ultrasound measurements showed a close 520 
and significant correlation between both readers (R2 = 0.86, p < 0.05) with a relatively small 95% 521 
confidence interval ranging from -0.57 to 0.62 in Bland-Altman plots.  522 
 523 
